| 000 | 01829 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517052957.0 | ||
| 264 | 0 | _c20160916 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.5601 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBorbely, Gabor | |
| 245 | 0 | 0 |
_aInduction of USP17 by combining BET and HDAC inhibitors in breast cancer cells. _h[electronic resource] |
| 260 |
_bOncotarget _cOct 2015 |
||
| 300 |
_a33623-35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAzepines _xpharmacology |
| 650 | 0 | 4 |
_aBenzamides _xpharmacology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Cycle Proteins |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEndopeptidases _xbiosynthesis |
| 650 | 0 | 4 |
_aEnzyme Induction _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHistone Deacetylase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMAP Kinase Signaling System |
| 650 | 0 | 4 | _aMCF-7 Cells |
| 650 | 0 | 4 |
_aNuclear Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xadministration & dosage |
| 650 | 0 | 4 |
_aRNA-Binding Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTranscription Factors _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTriazoles _xpharmacology |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 700 | 1 | _aHaldosen, Lars-Arne | |
| 700 | 1 | _aDahlman-Wright, Karin | |
| 700 | 1 | _aZhao, Chunyan | |
| 773 | 0 |
_tOncotarget _gvol. 6 _gno. 32 _gp. 33623-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.5601 _zAvailable from publisher's website |
| 999 |
_c25268917 _d25268917 |
||